Benign tumourSarcoma mimicICD-10 D17.x

Spindle cell / pleomorphic lipoma

SCL ยท pleomorphic lipoma ยท SCL/PL ยท pseudoangiomatous spindle cell lipoma

Spindle cell and pleomorphic lipomas are benign adipocytic tumours within a spectrum sharing a characteristic 13q14 deletion (RB1 / RCBTB2 / FOXO1 region). They classically present as slow-growing subcutaneous nodules on the posterior neck, shoulders or upper back of middle-aged or older men. The principal clinical relevance is as a benign mimic of liposarcoma โ€” particularly atypical lipomatous tumour and pleomorphic liposarcoma โ€” and recognition prevents over-treatment.

CurrentLast reviewed 22 May 2026

Epidemiology

  • Adults 40-70 years.
  • Male predominance (~9:1).
  • Posterior neck, shoulder, upper back โ€” "shawl distribution" classical.
  • Solitary; rarely multiple.
  • Slow growth over years; usually painless.

Pathology

  • Composed of mature adipocytes, bland spindle cells, mast cells and ropy collagen.
  • Spectrum from "pure" spindle cell lipoma to pleomorphic lipoma with multinucleated "floret" cells (giant cells with peripheral wreath-arranged nuclei).
  • 13q14 deletion / monosomy with loss of RB1, RCBTB2 and FOXO1-region material โ€” shared with mammary-type myofibroblastoma and cellular angiofibroma.
  • IHC: CD34+ (spindle cells), Rb loss; S100 negative in spindle cells (positive in adipocytes); MDM2 / CDK4 negative โ€” distinguishes from atypical lipomatous tumour.
  • No atypia, no mitoses, no necrosis.

Clinical features

  • Soft to firm, mobile, subcutaneous nodule.
  • 1-5 cm diameter typically; can grow larger.
  • Sites: posterior neck (commonest), shoulder, upper back; rarely cheek, scalp, oral.
  • Asymptomatic; rarely tender.
  • Overlying skin normal.
  • Slow growth.

Differentials

  • Lipoma (ordinary) โ€” softer, more lobulated, less characteristic site.
  • Atypical lipomatous tumour / well-differentiated liposarcoma โ€” deeper, larger, MDM2 / CDK4 amplification.
  • Pleomorphic liposarcoma โ€” high-grade; necrosis; atypia.
  • Angiolipoma โ€” tender; numerous small lesions.
  • Hibernoma โ€” brown-fat composition.
  • Solitary fibrous tumour โ€” CD34+; STAT6+; NAB2-STAT6 fusion.
  • Dermatofibroma / dermatofibrosarcoma protuberans โ€” different architecture; DFSP COL1A1-PDGFB.
  • Mammary-type myofibroblastoma โ€” shares 13q14 deletion.

Investigations

  • USS: well-defined hyperechoic mass with internal echoes.
  • MRI: characteristic fat-suppressed pattern; differentiates from liposarcoma (intermediate signal in non-fat areas raises concern).
  • Excisional biopsy for definitive diagnosis.
  • Pathology with IHC (CD34, Rb, MDM2, CDK4); molecular (13q14 FISH) if uncertain.

Management

  • Excision: complete local excision with thin margin is curative.
  • Recurrence rare with complete excision.
  • No metastatic potential.
  • No need for adjuvant therapy.
  • Counsel patient about benign nature and excellent prognosis.
  • Pathological clarification mandatory โ€” sarcoma exclusion always required.

References

  1. Enzinger FM, Harvey DA. Spindle cell lipoma. Cancer. 1975;36:1852-1859.
  2. Shmookler BM, Enzinger FM. Pleomorphic lipoma. Cancer. 1981;47:126-133.
  3. WHO Classification of Tumours Editorial Board. WHO Classification of Soft Tissue and Bone Tumours, 5th ed. Lyon: IARC; 2020.

Spot a correction?

If any clinical statement, citation or link on this page needs updating, please email admin@skinoncology.net with the page name, the proposed correction and the supporting source.